Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Eisai Prepares For Belviq Launch: An Interview With CEO Lonnel Coats

This article was originally published in The Pink Sheet Daily

Executive Summary

Eisai Inc.’s President and CEO Lonnel Coats discussed his approach to the U.S. obesity market and how he plans to position Belviq. The company needs to replace lost revenue from its off-patent blockbuster Aricept but Coats thinks he has the right mix of label, product and experience to win.


Related Content

REMS For Qsymia Limits Distribution, But Vivus To Explore Expanding Access


Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts